Oncology News | pharmaphorum

News

Enhertu gets breakthrough tag in HER2-low breast cancer

AstraZeneca and Daiichi Sankyo have claimed a fifth breakthrough designation from the FDA for Enhertu, shortly after showing the drug extended survival in patients with HER2-low metastatic

News

After bempeg failure, Nektar wields the axe

Nektar has said it will cut 70% of its workforce in the wake of the comprehensive failure in trials of its immuno-oncology candidate bempegaldesleukin, which was discontinued last week.

News

Nkarta leaps on early CAR-NK data in blood cancers

Shares in Nkarta more than doubled yesterday on the results of early-stage clinical that suggested it could be on to a winner with its natural kill (NK) cell therapy platform.

News

There are three types of white blood cells. T lymphocytes, B lymphocytes and natural killer cells.

Implants could transform CAR-T therapy into one-day procedur...

CAR-T therapies have revolutionised the treatment of some blood cancers, but are costly as well as time- and resource-intensive.

News

AstraZeneca Amenities Building - Mississauga - Sept 2005
Non exclusive, unlimited time license for print & web to WZMH Architects

AZ closes on FDA verdict on tremelimumab in liver cancer

AstraZeneca's anti-CTLA4 antibody tremelimumab is moving closer to what once looked like an extremely unlikely regulatory approval, after a string of negative trial results.

News

Roche's oral SERD giredestrant fails breast cancer trial

Roche revealed in its first-quarter results statement that giredestrant missed the mark in the phase 2 acelERA trial in advanced breast cancer, in what appears to be another blow to the eme

Enhertu gets breakthrough tag in HER2-low breast cancer

After bempeg failure, Nektar wields the axe

Nkarta leaps on early CAR-NK data in blood cancers

Implants could transform CAR-T therapy into one-day procedur...

AZ closes on FDA verdict on tremelimumab in liver cancer

Roche's oral SERD giredestrant fails breast cancer trial

Amazon puts $100m into global health drive

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks